Jennifer Richer, Ph.D., University of Colorado Anschutz Medical Campus (IMAGE)

University of Colorado Anschutz Medical Campus

Jennifer Richer, Ph.D., University of Colorado Anschutz Medical Campus

Caption

Jennifer Richer, Ph.D., and colleagues report promising results of phase 1 trial of enzalutamide and fulvestrant against advanced breast cancer.

Credit

University of Colorado Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.